Literature DB >> 2220810

DNA haplotype analyses of patients with hyperphenylalaninemia.

D Di Silvestre1, A Pandya, R Koch, J Groffen.   

Abstract

Linkage analysis of phenylketonurics has shown a strong association between the DNA haplotype at the phenylalanine hydroxylase (PAH) locus and phenylketonuria (PKU). Similarly, a genetic linkage between less severe forms of hyperphenylalaninemia (HPA) and the PAH locus has been suggested. In the present study we analyzed this linkage in more detail. Haplotypes at the PAH locus were determined for 19 individuals with moderately elevated plasma phenylalanine and normal urinary neopterin/biopterin ratios. Fourteen of these individuals had plasma phenylalanine levels of 4-10 mg/dl (mild HPA), and the other five had plasma phenylalanine levels of 10-19 mg/dl (atypical PKU). Thirteen of the 15 HPA families consisted of an affected child and at least one other sibling. Elevated plasma phenylalanine was seen to genetically segregate with specific PAH alleles in each family. Summation of the LOD scores for both categories of moderate plasma phenylalanine elevation gave a maximum value of 3.556 at theta = 0. At theta = 0 this gives a probability of linkage between the PAH locus and the locus for moderate phenylalanine elevations that is approximately 3,600:1. None of the alleles segregating with either mild HPA or atypical PKU were of haplotype 2 or 3, and 13/20 were of types 1 or 4. This is in agreement with the most deleterious mutations being on haplotypes 2 and 3 and with the less severe mutations being on haplotypes 1 and 4. chi 2 Analyses indicated no statistically significant correlation between HPA and a particular haplotype or restriction-enzyme site.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2220810      PMCID: PMC1683778     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Diagnosis in relationship to treatment of hyperphenylalaninaemia.

Authors:  M E Blaskovics
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

Review 2.  Phenylketonuria.

Authors:  R Koch; E Wenz
Journal:  Annu Rev Nutr       Date:  1987       Impact factor: 11.848

3.  Linkage disequilibrium between RFLP haplotype 2 and the affected PAH allele in PKU families from the Berlin area of the German Democratic Republic.

Authors:  O Riess; A Michel; A Speer; W Meiske; G Cobet; C Coutelle
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

4.  Human dihydropteridine reductase: characterisation of a cDNA clone and its use in analysis of patients with dihydropteridine reductase deficiency.

Authors:  H H Dahl; W Hutchison; W McAdam; S Wake; F J Morgan; R G Cotton
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 16.971

5.  Polymorphic DNA haplotypes at the phenylalanine hydroxylase locus in prenatal diagnosis of phenylketonuria.

Authors:  S P Daiger; A S Lidsky; R Chakraborty; R Koch; F Güttler; S L Woo
Journal:  Lancet       Date:  1986-02-01       Impact factor: 79.321

6.  Polymorphic DNA haplotypes at the human phenylalanine hydroxylase locus and their relationship with phenylketonuria.

Authors:  R Chakraborty; A S Lidsky; S P Daiger; F Güttler; S Sullivan; A G Dilella; S L Woo
Journal:  Hum Genet       Date:  1987-05       Impact factor: 4.132

7.  Intelligence and personality characteristics in adults with untreated atypical phenylketonuria and mild hyperphenylalaninemia.

Authors:  S E Waisbren; R Schnell; H L Levy
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

8.  Molecular analysis of the inheritance of phenylketonuria and mild hyperphenylalaninemia in families with both disorders.

Authors:  F D Ledley; H L Levy; S L Woo
Journal:  N Engl J Med       Date:  1986-05-15       Impact factor: 91.245

9.  Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.

Authors:  W Krause; M Halminski; L McDonald; P Dembure; R Salvo; D Freides; L Elsas
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

10.  Correlation between polymorphic DNA haplotypes at phenylalanine hydroxylase locus and clinical phenotypes of phenylketonuria.

Authors:  F Güttler; F D Ledley; A S Lidsky; A G DiLella; S E Sullivan; S L Woo
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

View more
  1 in total

1.  Different clinical manifestations of hyperphenylalaninemia in three siblings with identical phenylalanine hydroxylase genes.

Authors:  D DiSilvestre; R Koch; J Groffen
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.